Annual Operating Profit
-$63.32 M
-$128.40 K-0.20%
December 31, 2024
Summary
- As of March 10, 2025, SLN annual operating income is -$63.32 million, with the most recent change of -$128.40 thousand (-0.20%) on December 31, 2024.
- During the last 3 years, SLN annual operating profit has fallen by -$1.49 million (-2.40%).
- SLN annual operating profit is now -4291.97% below its all-time high of -$1.44 million, reached on December 31, 1995.
Performance
SLN Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$3.08 M
+$27.08 M+89.79%
December 1, 2024
Summary
- As of March 10, 2025, SLN quarterly operating income is -$3.08 million, with the most recent change of +$27.08 million (+89.79%) on December 1, 2024.
- Over the past year, SLN quarterly operating profit has stayed the same.
- SLN quarterly operating profit is now at all-time high.
Performance
SLN Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$61.66 M
+$15.82 M+20.42%
December 1, 2024
Summary
- As of March 10, 2025, SLN TTM operating income is -$61.66 million, with the most recent change of +$15.82 million (+20.42%) on December 1, 2024.
- Over the past year, SLN TTM operating profit has stayed the same.
- SLN TTM operating profit is now -400.97% below its all-time high of -$12.31 million, reached on September 30, 2020.
Performance
SLN TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
SLN Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.2% | 0.0% | 0.0% |
| 3 y3 years | -2.4% | 0.0% | 0.0% |
| 5 y5 years | -112.4% | 0.0% | 0.0% |
SLN Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.7% | at low | at high | +89.8% | -14.0% | +20.4% |
| 5 y | 5-year | -112.4% | at low | at high | +89.8% | -401.0% | +20.4% |
| alltime | all time | -4292.0% | at low | at high | +89.8% | -401.0% | +20.4% |
Silence Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$63.32 M(+0.2%) | - | - |
| Dec 2024 | - | -$3.08 M(-89.8%) | -$61.66 M(-20.4%) |
| Sep 2024 | - | -$30.16 M(+30.1%) | -$77.48 M(+23.3%) |
| Jun 2024 | - | -$23.17 M(+341.7%) | -$62.81 M(+16.1%) |
| Mar 2024 | - | -$5.25 M(-72.2%) | -$54.09 M(-15.3%) |
| Dec 2023 | -$63.19 M(+7.5%) | -$18.90 M(+22.0%) | -$63.89 M(+3.4%) |
| Sep 2023 | - | -$15.49 M(+7.2%) | -$61.78 M(+0.5%) |
| Jun 2023 | - | -$14.45 M(-4.0%) | -$61.49 M(-4.1%) |
| Mar 2023 | - | -$15.05 M(-10.3%) | -$64.13 M(+3.2%) |
| Dec 2022 | -$58.81 M(-4.9%) | -$16.78 M(+10.3%) | -$62.12 M(+2.2%) |
| Sep 2022 | - | -$15.21 M(-11.0%) | -$60.77 M(-2.1%) |
| Jun 2022 | - | -$17.09 M(+31.1%) | -$62.06 M(-1.3%) |
| Mar 2022 | - | -$13.03 M(-15.6%) | -$62.86 M(+0.3%) |
| Dec 2021 | -$61.83 M(+26.6%) | -$15.44 M(-6.4%) | -$62.66 M(-4.3%) |
| Sep 2021 | - | -$16.49 M(-7.8%) | -$65.51 M(+6.8%) |
| Jun 2021 | - | -$17.89 M(+39.3%) | -$61.33 M(+41.2%) |
| Mar 2021 | - | -$12.84 M(-29.8%) | -$43.44 M(+42.0%) |
| Dec 2020 | -$48.85 M(+63.9%) | -$18.29 M(+48.6%) | -$30.60 M(+148.6%) |
| Sep 2020 | - | -$12.31 M | -$12.31 M |
| Dec 2019 | -$29.81 M(+14.2%) | - | - |
| Dec 2018 | -$26.10 M(+34.2%) | - | - |
| Dec 2017 | -$19.45 M(+32.4%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$14.69 M(+1.5%) | - | - |
| Dec 2015 | -$14.47 M(-23.3%) | - | - |
| Dec 2014 | -$18.88 M(+26.2%) | - | - |
| Dec 2013 | -$14.96 M(+66.5%) | - | - |
| Dec 2012 | -$8.98 M(+8.9%) | - | - |
| Dec 2011 | -$8.25 M(-36.9%) | - | - |
| Dec 2010 | -$13.08 M(+24.0%) | - | - |
| Dec 2009 | -$10.55 M(-8.4%) | - | - |
| Dec 2008 | -$11.52 M(+3.1%) | - | - |
| Dec 2007 | -$11.17 M(+34.3%) | - | - |
| Dec 2006 | -$8.32 M(+22.3%) | - | - |
| Dec 2005 | -$6.80 M(+5.3%) | - | - |
| Dec 2004 | -$6.46 M(+35.3%) | - | - |
| Dec 2003 | -$4.77 M(+47.8%) | - | - |
| Dec 2002 | -$3.23 M(-26.6%) | - | - |
| Dec 2001 | -$4.40 M(+7.7%) | - | - |
| Dec 2000 | -$4.08 M(+15.9%) | - | - |
| Dec 1999 | -$3.52 M(+11.6%) | - | - |
| Dec 1998 | -$3.16 M(-11.5%) | - | - |
| Dec 1997 | -$3.57 M(+67.5%) | - | - |
| Dec 1996 | -$2.13 M(+47.8%) | - | - |
| Dec 1995 | -$1.44 M | - | - |
FAQ
- What is Silence Therapeutics annual operating income?
- What is the all time high annual operating profit for Silence Therapeutics?
- What is Silence Therapeutics annual operating profit year-on-year change?
- What is Silence Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Silence Therapeutics?
- What is Silence Therapeutics quarterly operating profit year-on-year change?
- What is Silence Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Silence Therapeutics?
- What is Silence Therapeutics TTM operating profit year-on-year change?
What is Silence Therapeutics annual operating income?
The current annual operating profit of SLN is -$63.32 M
What is the all time high annual operating profit for Silence Therapeutics?
Silence Therapeutics all-time high annual operating income is -$1.44 M
What is Silence Therapeutics annual operating profit year-on-year change?
Over the past year, SLN annual operating income has changed by -$128.40 K (-0.20%)
What is Silence Therapeutics quarterly operating income?
The current quarterly operating profit of SLN is -$3.08 M
What is the all time high quarterly operating profit for Silence Therapeutics?
Silence Therapeutics all-time high quarterly operating income is -$3.08 M
What is Silence Therapeutics quarterly operating profit year-on-year change?
Over the past year, SLN quarterly operating income has changed by $0.00 (0.00%)
What is Silence Therapeutics TTM operating income?
The current TTM operating profit of SLN is -$61.66 M
What is the all time high TTM operating profit for Silence Therapeutics?
Silence Therapeutics all-time high TTM operating income is -$12.31 M
What is Silence Therapeutics TTM operating profit year-on-year change?
Over the past year, SLN TTM operating income has changed by $0.00 (0.00%)